Nucleotide supplementation: a randomised double-blind placebo controlled trial of IntestAidIB in people with Irritable Bowel Syndrome [ISRCTN67764449]

Dancey, Christine P. and Attree, Elizabeth A. and Brown, K.F. (2006) ‘Nucleotide supplementation: a randomised double-blind placebo controlled trial of IntestAidIB in people with Irritable Bowel Syndrome [ISRCTN67764449]’, Nutrition Journal (doi:10.1186/1475-2891-5-16).

[img]
Preview
Text
Dancey, C.P et al(2006) Nutrition Journal 5 16.pdf - Published Version
Available under License Creative Commons Attribution No Derivatives.

Download (306Kb) | Preview

Abstract

Work with infants has shown that the incidence and duration of diarrhoea is lower when nucleotide supplementation is given, and animal work shows that villi height and crypt depth in the intestine is increased as a result of dietary nucleotides. Dietary nucleotides may be semi-essential under conditions of ill-health, poor diet or stress. Since people with Irritable Bowel Syndrome tend to fulfil these conditions, we tested the hypothesis that symptoms would be improved with dietary nucleotide supplementation on thirty-seven people with a diagnosis of Irritable Bowel. The study found that dietary nucleotide supplementation improved some of the symptoms of irritable bowel above baseline and placebo level.

Item Type: Article
Additional Information: Citation: Dancey, C.P., Attree, E.A., Brown, K.F. (2006) ‘Nucleotide supplementation: a randomised double-blind placebo controlled trial of IntestAidIB in people with Irritable Bowel Syndrome [ISRCTN67764449] ' Nutrition Journal 5:16.
Divisions: Schools > Psychology, School of
Depositing User: Mr Stephen Grace
Date Deposited: 07 Aug 2009 15:38
Last Modified: 15 Aug 2013 08:50
URI: http://hdl.handle.net/10552/239

Actions (login required)

View Item View Item